medical-imaging-2016_scientifictracks-abstracts

5 / 28

Notes:
Page 24
Medical Imaging 2016
October 20-21, 2016
Volume 5, Issue 5(Suppl) OMICS J Radiol
ISSN: 2167-7964 ROA, an open access journal
conferenceseries .com
October 20-21, 2016 Chicago, USA
International Conference on
Medical Imaging & Diagnosis
Bital Savir-Baruch, OMICS J Radiol 2016, 6:5(Suppl)
The role of nuclear medicine in early breast cancer diagnosis - “How do we do?”
Bital Savir-Baruch
Loyola University Medical Center, USA
Breast cancer is the most common diagnosed cancer worldwide. Since the introduction of mammography as gold standard
for screening purposes in the diagnosis of breast cancer, mortality decreased significantly. However, its performance
in a population with dense breast is very low. Among all screening women, approximately 48% women will present with
heterogeneously or extremely dense breast. Low performance of mammography is likely due to overlying glandular tissue
masking tumor lesions. Hence, other modalities such as molecular breast imaging are been evaluated. Tc99m Sestamibi
Molecular Breast Imaging (MBI) has demonstrated significantly higher sensitivity and equivalent specificity in the detection
of breast cancer among high risk women when compared to mammography and is thus being used increasingly as an adjunct
to mammography and ultrasound in selected women. Large trial by Rhodes et. al. evaluated the performance of MBI using as
low as 8 mCi of Tc99m Sestamibi in the screening of high risk women with mammographically dense breasts. MBI sensitivity
was significantly higher than that of mammography, 81% versus 24%, with same specificity of 93% vs. 89%. However, when
compared to mammography, nuclear medicine breast modality generates all body radiation dose. When targeting a younger
population with increased probability of having dense breast, appropriate risk to benefit ratio has to be established. In this
presentation, we will review the role of nuclear medicine in the diagnosis of early breast cancer.
Biography
Bital Savir-Baruch is a board certified Nuclear Medicine Physician. She received her Medical degree from Semmelweis University, Budapest, Hungary. She
completed the Nuclear Medicine residency program at Emory university Hospital, Atlanta, GA, In 2014, she joined Loyola University Medical Center, Maywood,
Illinois as an Assistant Professor of Radiology.